Enhanced potential for oxidative stress in livers of senescent rats by the peroxisome proliferator-activated receptor alpha agonist perfluorooctanoic acid

被引:20
作者
Badr, MZ
Birnbaum, LS
机构
[1] Univ Missouri, Kansas City, MO 64108 USA
[2] US EPA, Natl Hlth & Environm Effects Res Lab, Res Triangle Pk, NC 27711 USA
关键词
liver; rats; PPAR agonists;
D O I
10.1016/j.mad.2003.10.006
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Aging sensitizes the liver to the hepatocarcinogenic effect of PPARalpha agonists via unknown mechanisms. This study was designed to investigate age-dependent, hepatic effects of the non-metabolizable PPARalpha agonist perfluorooctanoic acid (PFOA) on the delicate balance between activities of pathways involved in H2O2 production and elimination. Male Fischer-344 rats, ranging in age from juvenile (4 weeks old), post puberty (10 weeks old), mature adulthood (20 weeks old), middle age (50 weeks old), to senescence (100 weeks old), were treated intragastrically with either 150 mg PFOA/kg in 0.5 ml corn oil, or with corn oil alone. Animals were sacrificed at predetermined time-points ranging from 0-28 days post PFOA or oil administration. Hepatic peroxisomal beta-oxidizing activities were significantly elevated (four- to six-fold) in all age groups by PFOA. While levels declined to near basal values within 3-7 days in 4 and 10, they remained elevated for an additional week in 20-, 50- and 100-week-old rats. However, catalase activity was significantly lower in senescent livers compared with all other groups. In conclusion, aging does not appear to hinder the capacity of the liver to produce excess H2O2 through peroxisomal beta-oxidation upon exposure to PPAR agonists. However, the reduced ability of the senescent liver to recover from PFOA-induced potential increase in H2O2 production, coupled with the apparent diminished capacity of this liver to decompose H2O2, enhances the potential for hepatic oxidative damage in aged animals. This may explain the enhanced susceptibility of the senescent liver to the hepatocarcinogenic effect of PPAR agonists. (C) 2003 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:69 / 75
页数:7
相关论文
共 25 条
[1]  
Aebi H., 1974, Methods in Enzymatic Analysis, V2, P674, DOI [DOI 10.1016/B978-0-12-091302-2.50032-3, 10.1016/B978-0-12-091302-2.50032-3]
[2]  
BADR M, 1991, TOXICOLOGIST, V187, P11
[3]   AGE-RELATED SUSCEPTIBILITY TO THE CARCINOGENIC EFFECT OF THE PEROXISOME PROLIFERATOR WY-14,643 IN RAT-LIVER [J].
CATTLEY, RC ;
MARSMAN, DS ;
POPP, JA .
CARCINOGENESIS, 1991, 12 (03) :469-473
[4]  
CAYEN MN, 1983, PROG DRUG METAB, V7, P173
[5]   THE NEED FOR MULTIPLE TIME POINTS IN AGING STUDIES [J].
COLEMAN, P ;
FINCH, C ;
JOSEPH, J .
NEUROBIOLOGY OF AGING, 1990, 11 (01) :1-2
[6]   Lipid peroxidation and advanced glycation end products in the brain in normal aging and in Alzheimer's disease [J].
Dei, R ;
Takeda, A ;
Niwa, H ;
Li, M ;
Nakagomi, Y ;
Watanabe, M ;
Inagaki, T ;
Washimi, Y ;
Yasuda, Y ;
Horie, K ;
Miyata, T ;
Sobue, G .
ACTA NEUROPATHOLOGICA, 2002, 104 (02) :113-122
[7]  
HALLIWELL B, 1990, METHOD ENZYMOL, V186, P1
[8]   INDUCTION OF PEROXISOMES BY TREATMENT WITH PERFLUOROOCTANOATE DOES NOT INCREASE RATES OF H2O2 PRODUCTION IN INTACT LIVER [J].
HANDLER, JA ;
SEED, CB ;
BRADFORD, BU ;
THURMAN, RG .
TOXICOLOGY LETTERS, 1992, 60 (01) :61-68
[9]  
HUBER W, 1991, CANCER RES, V51, P1789
[10]  
Ikeyama S, 2002, FASEB J, V16, pA1163, DOI 10.1096/fj.01-0409fje